Screener
Aquestive Therapeutics, Inc. AQST Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$22.86M-68.8% | -$8.06M+64.9% | -$31.86M-86.8% | -$15.45M-34.2% | -$13.55M-394% | ||
| $136K-2.9% | $113K-18.7% | $130K-11.6% | $139K-12.6% | $140K-31.7% | ||
| $2.9M+53.7% | $2.32M+46.1% | $1.38M-42.7% | $2.78M+76.1% | $1.88M+22.4% | ||
| -$9.44M-19.3% | -$14.81M+36.7% | -$8.47M-30.5% | -$12.65M-6.5% | -$7.91M-13.0% | ||
| $212K+98.1% | $52K-61.5% | $85K+467% | $235K+194% | $107K+206% | ||
| -$212K-98.1% | -$52K+61.5% | -$85K-467% | -$235K-194% | -$107K-206% | ||
| —— | —— | —— | —— | —— | ||
| $44.99M+749,967% | $8K+33.3% | —— | —— | -$6K-204% | ||
| —— | $4.42M-78.6% | $660K+320% | $81.41M— | $0-100% | ||
| -$12.24M-50.8% | -$10.44M-261% | —— | $68.53M— | -$8.12M— | ||
| -$9.65M-20.3% | -$14.86M+36.9% | -$8.55M-31.5% | -$12.88M-7.7% | -$8.02M-13.9% |
FAQ
- How much cash does Aquestive Therapeutics, Inc. generate?
- Aquestive Therapeutics, Inc. (AQST) generated -$45.4M in operating cash flow over the trailing twelve months.
- What is Aquestive Therapeutics, Inc.'s free cash flow?
- After $584.0K of capital expenditures, Aquestive Therapeutics, Inc.'s free cash flow was -$45.9M over the trailing twelve months, up 8.1% year over year.
- Where does Aquestive Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Aquestive Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
